James Wallace to Colorectal Neoplasms
This is a "connection" page, showing publications James Wallace has written about Colorectal Neoplasms.
Connection Strength
0.120
-
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer. Clin Colorectal Cancer. 2013 Sep; 12(3):218-22.
Score: 0.055
-
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Jun; 30(3):1211-5.
Score: 0.047
-
Shared Goal Setting in Team-Based Geriatric Oncology. J Oncol Pract. 2016 11; 12(11):1115-1122.
Score: 0.017